Project Details
Description
A Phase 3 randomized, open-label, active-controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of GSK1278863 compared to darbepoetin al
Status | Finished |
---|---|
Effective start/end date | 10/1/16 → 12/31/24 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.